Stand up for the facts!
Our only agenda is to publish the truth so you can be an informed participant in democracy.
We need your help.
I would like to contribute
If Your Time is short
• Under the Senate Democratic bill, the federal government would see its outlays reduced by about $300 billion as a result of a Medicare negotiation provision. However, that reduction wouldn’t represent cuts to Medicare beneficiaries.
• Instead, by leveraging Medicare’s market power, the government would be able to pay less to provide the same medicines.
As Senate Democrats race to pass what could be their final piece of major legislation before the midterm elections, critics have gone to the airwaves to blast the proposal as hurting older Americans who rely on Medicare.
Here’s the narration of one ad, sponsored by a group called the American Prosperity Alliance:
"Higher gas prices, higher grocery bills, everything today is costing too much. Now, Congress is considering a bill that will strip $300 billion dollars from Medicare, money older Americans rely on for their medicine, their treatments, their cures. We are all paying more today, but stripping $300 billion from Medicare? It’s simply too much. So call Congress and tell them to oppose (President Joe) Biden's reckless spending package."
The ad misleadingly paints what is more accurately characterized as nearly $300 billion in savings for consumers and taxpayers.
The American Prosperity Alliance has almost no online profile. Its website provides only a link to the ad, and no identifying information or even any pages beyond the homepage. When we asked a better-known group with a similar name, Americans for Prosperity, whether the American Prosperity Alliance was an affiliate, a spokesman, Bill Riggs, said, "This is NOT our ad and we are not affiliated with this group."
The ad echoes a theme seen in other attacks on the Democratic-backed proposal, including one the Washington Post Fact Checker gave three Pinocchios out of four in June, meaning it contains "significant factual error and/or obvious contradictions." PolitiFact rated a similar ad False in July.
The bill, which also includes major provisions on climate change and corporate taxation, appears to be on track to secure the support of all 50 Senate Democrats, which when combined with the vice president’s tie-breaking vote, would be enough to pass even if all Republicans vote against it. The bill would be taken up under a procedural status known as reconciliation that allows bills to pass with a simple majority rather than requiring a 60-vote supermajority to proceed to a final vote.
The problem with the ad’s $300 billion claim is it frames the spending decline as hurting older Americans who are insured under Medicare. That’s not so.
Rather, the $300 billion — technically, almost $288 billion, according to the latest Congressional Budget Office analysis — stems from a provision in the Democratic bill that would end the longstanding bar on Medicare from negotiating with drugmakers over the price of certain medicines. Not being able to negotiate prices has meant that Medicare — the pharmaceutical market’s biggest single buyer — could not leverage its weight to secure lower prices for taxpayers.
The bill is projected to reduce federal spending by almost $300 billion, but that would reflect government savings and not benefit cuts; Medicare recipients would receive the same amount of medicines.
"In reality, the bill's prescription drug savings would save the federal government nearly $300 billion through 2031 without cutting benefits," wrote the Committee for a Responsible Federal Budget, a group that favors deficit reduction and has been skeptical of many of Biden’s legislative efforts, citing their cost.
"Lowering Medicare costs is not the same as reducing benefits," the committee wrote. "Quite the opposite — many measures to reduce costs for the government would reduce costs for individuals as well."
After combining the drug-cost savings with the bill’s other health care provisions, Medicare beneficiaries would see decreases in premiums and out-of-pocket costs, including through a $2,000 annual cap on out-of-pocket costs, the committee projected. "In addition to saving the government nearly $300 billion, the (bill) would save American families nearly $300 billion more," the committee has projected.
Steve Ellis, president of Taxpayers for Common Sense, another group that seeks to keep deficits low, told PolitiFact he agrees that the ad’s portrayal of the bill is problematic.
"Those are savings resulting mostly from the government negotiating prescription drug prices and limiting drug price increases to inflation," Ellis said. "So rather than taking money out of Medicare, it is reducing Medicare costs."
The American Prosperity Alliance said in an ad that the Senate Democrats’ reconciliation bill "will strip $300 billion dollars from Medicare."
The federal government would see its outlays reduced by about $300 billion as a result of a Medicare drug-price negotiation provision. However, that reduction wouldn’t represent cuts to Medicare beneficiaries.
Rather, by leveraging Medicare’s market power, the government would be able to pay less to provide the same medicines.
We rate the statement False.
American Prosperity Alliance, ad, accessed Aug. 4, 2022
American Prosperity Alliance, homepage, accessed Aug. 5, 2022
Draft of H.R. 5376
Congressional Budget Office, "Estimated Budgetary Effects of H.R. 5376, the Inflation Reduction Act of 2022," Aug. 3, 2022
Committee for a Responsible Federal Budget, "CBO Estimates Drug Savings for Reconciliation," July 8, 2022
Committee for a Responsible Federal Budget, "IRA Would Lower Medicare Costs, NOT Cut Benefits," Aug. 2, 2022
Washington Post, "Democrats, Sinema reach deal on Inflation Reduction Act, after key changes to tax policies," Aug. 4, 2022
Washington Post Fact Checker, "Ad targeting Manchin on prescription drugs uses misleading math," June 17, 2022
Huffington Post, "Drugmakers Try To Scare Seniors In Last-Ditch Effort To Stop Democrats’ Economic Plan," Aug. 5, 2022
PolitiFact, "Ad targeting Manchin, AARP misses on Medicare drug price negotiations,"July 25, 2022
Email interview with Bill Riggs, spokesman for Americans for Prosperity, Aug. 5, 2022
Email interview with Steve Ellis, president of Taxpayers for Common Sense, Aug. 5, 2022
Read About Our Process
In a world of wild talk and fake news, help us stand up for the facts.